01
Cash & equivalents decreased 11.9%
Cash & equivalents changed -11.9% from the comparable as-filed period.
$84.9M→$74.9MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTPROKIDNEY CORP.'s latest supported as-filed period reports net income of -$28.4M, 71.7% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed -11.9% from the comparable as-filed period.
Net income changed -71.7% from the comparable as-filed period.
Operating income changed -21.8% from the comparable as-filed period.
Research & development changed +39.5% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
PROK · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-359349SEC ↗8-KAug 10, 2026Period Aug 10, 20260001193125-26-342397SEC ↗10-QAug 10, 2026Period Jun 30, 20260001193125-26-342373SEC ↗4Aug 6, 2026Period Aug 4, 20260001193125-26-336856SEC ↗4Jul 6, 2026Period Jul 1, 20260001193125-26-296160SEC ↗4Jun 15, 2026Period Jun 12, 20260001193125-26-271337SEC ↗4May 29, 2026Period May 28, 20260001193125-26-248262SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 20, 2026Filed Aug 20, 2026 | Pereira Brian JGDirector | Open Market SaleIndirect | 222,948 | $1 | $316,564 | Form 4 ↗ |
| Aug 20, 2026Filed Aug 20, 2026 | Pereira Brian JGDirector | Open Market SaleDirect | 27,052 | $1 | $38,411 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Pereira Brian JGDirector | Open Market SaleIndirect | 222,949 | $1 | $321,203 | Form 4 ↗ |
| Aug 19, 2026Filed Aug 20, 2026 | Pereira Brian JGDirector | Open Market SaleDirect | 27,051 | $1 | $38,972 | Form 4 ↗ |
| Aug 18, 2026Filed Aug 20, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed -14.5% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-248259| Pereira Brian JGDirector |
| Open Market SaleIndirect |
| 229,338 |
| $1 |
| $314,468 |
| Form 4 ↗ |
| Aug 18, 2026Filed Aug 20, 2026 | Pereira Brian JGDirector | Open Market SaleDirect | 27,826 | $1 | $38,155 | Form 4 ↗ |